Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3073599 | 1.00 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL2635052 | 1.00 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL319408 | 1.00 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Hydrochloric Acid SCHEMBL8587068 | 0.98 | LMNA (0.44) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL10534255 | 0.94 | LMNA (0.41) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL122818 | 0.94 | LMNA (0.42) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL11424155 | 0.94 | LMNA (0.42) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL640184 | 0.94 | LMNA (0.42) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Phosphoric Acid SCHEMBL5789520 | 0.93 | LMNA (0.39) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Acetic Acid SCHEMBL7951061 | 0.93 | USP2 (0.44) | LMNAL3MBTL1TDP1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4140504-B1 | MICELLE MADE FROM BENZIMIDAZOLE-CARBOHYDRATE CONJUGATE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF AS ANTICANCER AGENT OR ANTIVIRAL AGENT COMPRISING THE SAME | BIOMETRIX TECH INC (KR) | 2025-01-15 | — | — | EP | claimed |
| CN-115721606-B | Micelle, preparation method thereof and pharmaceutical composition comprising micelle | 博美利克斯技术公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118459618-A | Novel galactosylated glycosaminoglycan and preparation method and application thereof | 中国科学院昆明植物研究所 | 2024-08-09 | — | — | CN | claimed |
| US-11998530-B2 | Micelle comprising benzimidazole-carbohydrate conjugate compound, preparation method thereof and use thereof as anticancer agent or antiviral agent comprising the same | BIOMETRIX TECHNOLOGY INC. (KR) | 2024-06-04 | — | — | US | claimed |
| US-20230248702-A1 | MICELLE COMPRISING BENZIMIDAZOLE-CARBOHYDRATE CONJUGATE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF AS ANTICANCER AGENT OR ANTIVIRAL AGENT COMPRISING THE SAME | BIOMETRIX TECHNOLOGY INC. (KP) | 2023-08-10 | — | — | US | claimed |
| CN-111345426-B | Food preservative | 中山市南方新元食品生物工程有限公司 | 2023-06-30 | — | — | CN | claimed |
| EP-4169930-A1 | NOVEL BENZIMIDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF AS ANTICANCER OR ANTIVIRAL AGENT | Biometrix Technology Inc. (KR) | 2023-04-26 | — | — | EP | claimed |
| WO-2023027236-A1 | MICELLE COMPRISING BENZIMIDAZOLE-CARBOHYDRATE CONJUGATE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF AS ANTICANCER AGENT OR ANTIVIRAL AGENT | (주)바이오메트릭스 테크놀로지 | 2023-03-02 | — | — | WO | claimed |
| EP-4140504-A1 | MICELLE COMPRISING BENZIMIDAZOLE-CARBOHYDRATE CONJUGATE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF AS ANTICANCER AGENT OR ANTIVIRAL AGENT COMPRISING THE SAME | Biometrix Technology Inc. (KR) | 2023-03-01 | — | — | EP | claimed |
| CN-114685583-A | Glycoside compounds, preparation method and application thereof | 西格莱(苏州)生物医药有限公司 | 2022-07-01 | — | — | CN | claimed |
| US-20040204599-A1 | Group of novel anti-cancer compounds with specific structure | YANG'S BIOCHEM CO. LTD. | 2004-10-14 | — | — | US | claimed |
| EP-1463707-A2 | A GROUP OF NOVEL ANTI-CANCER COMPOUNDS WITH SPECIFIC STRUCTURE | Yang, Zhenhua (US) | 2004-10-06 | — | — | EP | claimed |
| US-20040034242-A1 | Group of anti-cancer compounds with specific structure and their production method | YANG ZHENHUA (US) | 2004-02-19 | — | — | US | claimed |
| WO-2003014296-A2 | A GROUP OF NOVEL ANTI-CANCER COMPOUNDS WITH SPECIFIC STRUCTURE | YANG ZHENHUA (US) | 2003-02-20 | — | — | WO | claimed |
| CN-1098861-C | Process for preparing amino-glucose metallic matching substance | XIANGTAN NORMAL COLLEGE (CN) | 2003-01-15 | — | — | CN | claimed |
| EP-1259470-A2 | A GROUP OF ANTI-CANCER COMPOUNDS WITH SPECIFIC STRUCTURE AND THEIR PRODUCTION METHOD | Yang, Zhenhua (US) | 2002-11-27 | — | — | EP | claimed |
| WO-2001059067-A2 | A GROUP OF ANTI-CANCER COMPOUNDS WITH SPECIFIC STRUCTURE AND THEIR PRODUCTION METHOD | YANG ZHENHUA (US) | 2001-08-16 | — | — | WO | claimed |
| CN-1251368-A | Process for preparing amino-glucose metallic matching substance | XIANGTAN NORMAL COLLEGE (CN) | 2000-04-26 | — | — | CN | claimed |
| EP-0557441-B1 | N-HALOCHITOSANS, THEIR PREPARATION AND USES | VANSON LP (US) | 1995-05-10 | — | — | EP | claimed |
| US-5362717-A | Chitians as flocculants | VANSON L. P. (US) | 1994-11-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204599-A1 | Group of novel anti-cancer compounds with specific structure | FASN, NFKBIA, NFATC1 | LMNA 3514/4885L3MBTL1 1397/4885TDP1 4761/4885 |
| US-11998530-B2 | Micelle comprising benzimidazole-carbohydrate conjugate compound, preparation method thereof and use thereof as anticancer agent or antiviral agent comprising the same | RB1, CCNI, CA14 | LMNA 1411/4885L3MBTL1 1006/4885TDP1 2968/4885 |
| US-20230248702-A1 | MICELLE COMPRISING BENZIMIDAZOLE-CARBOHYDRATE CONJUGATE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF AS ANTICANCER AGENT OR ANTIVIRAL AGENT COMPRISING THE SAME | RB1, CCNI, CA14 | LMNA 1411/4885L3MBTL1 1006/4885TDP1 2968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.